Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/5/04 → 06/21/08 |
Funding
- GlaxoSmithKline: $5,848.08
International 6-Month Study of Efficacy and Safety of Valaciclovir 1g QD vs Placebo for the Suppression of HSV-2 Genital Herpes in Newly Infected Immunocompetent Subjects
- Baker, David A. (CoPI)
- Garry, David J. (CoI)
- Ravishankar, Viswanathan (PI)
Project: Research